Eligin helps to boost immunity against respiratory infections
Two years ago a concentrated form of high-quality organic ginger under the name Kitl Eligin Organic appeared on the market. Many experts, led by the leading Czech immunologist prof. MUDr. Jirina Bartunkova, DrSc. "According to clinical observations, Eligin reduces, among other things, the morbidity caused by pathogens transmitted by droplet infection," says the professor. These pathogens include, for example, influenza viruses, rhinoviruses and coronaviruses.
Eligin is produced by Kitl from high-quality ginger, which contains above-average active ingredients. It is for them that people use ginger in infectious diseases, immune disorders. According to clinical observations, the ginger contained in Eligin reduces the morbidity caused by pathogens transmitted by the droplet infection.*) Such pathogens include influenza viruses, rhinoviruses and coronaviruses.
Active ingredients of ginger
The main charm of ginger lies mainly in two active substances: 6-gingerol and 6-shogaol. The ginger from which Kitl Eligin Organic is made comes from Indonesia and is a product of organic farming.
However, the high content of active ingredients in the rhizome is not enough in itself. The ginger needs to be adjusted accordingly. Eligin managed to maximize the amount of both 6-gingerol and 6-shogaol thanks to a specific manufacturing process called elicitation.
"And because ginger alone contains only trace amounts of vitamin C, we have added a defined amount of this vitamin to the end product that potentiates the effects of ginger," adds Professor Bartůňková. In addition, the addition of vitamin C allows an increase in the content of 6-shogaol.
The ginger powder in Eligin is coated with a special enteric capsule. As a result, it dissolves in the intestine after ingestion. Thus, its burning effect in the esophagus or stomach can be avoided. Eligin can be used by adults and children from 6 years of age.
Eligin is registered as a food supplement. No clinical studies have been conducted with Eligin. More at www.eligin.com.
* Theoretical assumption and clinical observations. Not confirmed by clinical studies.